Completion and Termination. This Settlement Agreement shall terminate 24 months after the latest of the following dates:
a. The date the Court approves the final plan for regular testing.
b. The date the Court approves the final plan for confirmation of a Suitable Representative.
c. The date the new resource allocation model is fully implemented. The new resource allocation model will be deemed “fully implemented” on the day in which class members’ budgets are no longer being calculated using the Budget Tool, but are instead being determined by the new resource allocation model outlined in Section V.A.1-2. of this Agreement.
Completion and Termination. The Trustee may terminate the Grant at any time without liability for compensation with immediate effect by written notice to the Grantee upon occurrence of the following non-compliance events: (1) failure to carry out the Project; (2) breach of any terms, conditions or undertakings; (3) the objective of the Project has substantially deviated from the one stated in the Approved Project Proposal; (4) assignment of the Agreement by the Grantee without consent from the Trustee; (5) engage in any conduct prejudicial to the Project or the SIE Fund; (6) winding-up and/or insolvency of the Grantee; (7) failure to submit reports or any information or the information submitted is incomplete, incorrect, untrue or is misleading to a material extent; or (8) the Grantee or its key management is convicted of a criminal offence by a court in Hong Kong or commit fraudulent or other inappropriate acts which may in the Trustee’s opinion, adversely impact the implementation of the Project and/or the reputation of the Project or the SIE Fund. Subject to the prior written approval of the Trustee, the Grantee may terminate the Grant without cause by giving at least 14 days’ notice to the Trustee provided that the Grantee shall return to the Trustee all or any part of the Grant paid to the Grantee with interest. The Trustee may terminate this Agreement without cause and without entitling the Grantee any compensation whatsoever by giving at least 14 days’ notice to the Grantee.
Completion and Termination. The Completion shall take place on 30 September 2022 (being the Completion Date). Following the completion of the Proposed Transfer and the termination of the strategic cooperation with Arla, the Group will cease to distribute products manufactured by Arla (save for the transactions contemplated under the Transition Services Agreement). If Completion does not take place on the Completion Date because the Sellers fail to comply with any of its relevant obligations in accordance with the Business Transfer Agreements, the Buyers may by notice to the Sellers proceed to Completion to the extent reasonably practicable, postpone Completion to such date as the Buyers may specify, or terminate the Business Transfer Agreements.
Completion and Termination. If all the Conditions are satisfied or otherwise waived
Completion and Termination. (a) This Agreement will continue in full force and effect until completion of the work unless it is terminated at an earlier date by any party as outlined below;
(b) Any signatory to this Agreement may terminate this Agreement by giving no less than fourteen (14) days’ written notice of the intent to terminate this Agreement. Notice shall be considered given when deposited in the United States mail, postage prepaid, and addressed as provided in Section 6 below;
(c) In the event of termination of this Agreement by any participant prior to completion and final payment by that participant, the participant will pay Urbana its share of the costs for all services performed up to that party’s total proportionate share of the project costs which were actually and satisfactorily rendered up to date of termination.
Completion and Termination. The contractual relationship closes at the end of the arranged time. In mutual agreement it can be terminated before. The contract can only be terminated for important reasons. The termination has to be done in writing.
Completion and Termination. Each party may terminate this AGREEMENT on thirty (30) days prior written notice to the other parties. Any confidential PPMS documentation remaining in the possession of EVALUATOR upon completion of the EVALUATION PERIOD or early termination of the AGREEMENT, whichever is earlier, and in the absence of any further agreement between the parties will be destroyed or, at the request of STRATOCORE, returned to STRATOCORE and all of EVALUATOR rights to access PPMS shall end. Subject to Section 6, upon completion of the EVALUATION PERIOD or early termination, whichever is earlier, and in the absence of any further agreement between the parties, the Parties shall cease all use and make no further use of the INFORMATION disclosed to it and shall, upon written request from the disclosing party, promptly return to the other party all of the INFORMATION which is in tangible form, except that each party shall be permitted to retain one copy of the other party’s INFORMATION in its legal department so that any continuing obligations may be determined.
Completion and Termination. 5.1 Completion shall take place on the Completion Date:
(a) at the offices of the Buyer’s Lawyers at Efsxxxxxxx 0, 000 Xxxxxxxxx, Xxxxxxx; xr
(b) at any other place or time as agreed in writing by the Sellers and the Buyer.
5.2 Completion Date means 14 September 2011, but subject to clause 5.9 and clause 2.4, if the Conditions have not been satisfied or waived in accordance with clause 2 on or before that date, means:
(a) the fifth Business Day after the Conditions are satisfied or waived;
(b) any other date agreed in writing by the Sellers and the Buyer; or
(c) the date to which Completion is deferred in accordance with clause 5.6.
5.3 The Sellers undertake to the Buyer that the Business shall be conducted in the manner provided in Part 1 of Schedule 4 from the date of this Agreement until Completion and give the Buyer the undertakings set out in that Schedule.
5.4 At, or immediately prior to, Completion the Sellers shall:
(a) deliver or cause to be delivered the documents and evidence set out in Part 2 of Schedule 4; and
(b) deliver any other documents referred to in this Agreement as being required to be delivered by them; and
(c) cause completion under the IP Asset Transfer Agreement.
Completion and Termination. UPM shall have the right to terminate this Agreement at any time if Client fails to make a required payment timely, or if new toxicological information shows the API or Product to have materially higher toxicity than previously reported, or if new Federal or State regulations or publications are issued affecting the Product. UPM shall also have the right to terminate this Agreement in the event that the Client files a petition for relief under the United States Bankruptcy Code, as now constituted or hereafter amended, or any other applicable federal or state insolvency or other similar law or; an entry of a decree or order for relief by a court having jurisdiction in the premises in respect of Client in an involuntary case under the United States Bankruptcy Code, as now constituted or hereafter amended or any other applicable federal or state insolvency or other similar law and the continuance of any such decree or order unstayed and in effect for a period of sixty (60) consecutive days. Additionally, in the event Client unilaterally stops or delays the Project for any reason for a period of sixty (60) days or longer, UPM may, in its sole discretion, elect to either (a) terminate this Agreement, or (b) amend the timeline and revise the Project costs to account for such Client delay. In such events, UPM may retain the down payment and all payments made to the date of 1ermination. Client also shall be liable for all unpaid amounts for supplies and work done up to and including the date of termination. Client shall have the right to terminate this Agreement upon thirty (30) days prior written notice. Upon termination, the parties will continue to be bound by accrued rights, and will only be relieved of future obligations to make payments for work not yet done and to deliver materials not yet produced. The rights and obligations of the parties pursuant to Sections III 5, 7, 9, 11, 12, 13 and 14 shall survive the termination or expiration of this Agreement. Upon early termination of this Agreement, Client analytical samples (API and clinical trial material) will be retained at UPM’s facility for thirty (30) days after which time they will be discarded.
Completion and Termination. 12.1 This Agreement shall be effective as of the date first set out above and shall continue in full force and effect until the Clinical Trial is completed unless otherwise extended, renewed, or amended by mutual written consent or unless terminated earlier in accordance with Articles 12.2, 12.3 or 12.4 of this Agreement.
12.2 Any Party hereto may terminate this Agreement before completion, upon written notice to all the other Parties, if any other Party materially breaches this Agreement and fails to cure such breach within thirty (30) days after receipt of written notice thereof from the non-breaching Party or Parties.
12.3 In addition to termination for breach as specified in Article 12.2, any Party may terminate this Agreement upon sixty (60) days written notice to the other Parties without cause.
12.4 Where Subject safety is a concern, any Party may terminate the Agreement immediately. If the Protocol is not approved by the REB, or if the Clinical Trial is suspended or approval is withdrawn by the REB, the INSTITUTION may terminate the Agreement immediately.
12.5 If the INVESTIGATOR is unavailable to continue the Clinical Trial, the SPONSOR and the INSTITUTION may agree (i) to continue the Clinical Trial with a replacement investigator or (ii) to terminate the Agreement.
12.6 In the event of termination the SPONSOR shall reimburse the INVESTIGATOR and the INSTITUTION for any and all expenses and non-cancellable obligations incurred before the date of receipt of such notice by the other Parties, plus all reasonable costs associated with shutting down the Clinical Trial. In addition, the SPONSOR shall reimburse the INSTITUTION for all payments owing to it up to receipt of the written notice of termination in accordance with Schedule A.
12.7 In the event of termination of the Agreement for any reason, the SPONSOR shall continue to supply sufficient quantities of the Study Drug(s) as required to allow the INVESTIGATOR to safely terminate the participation of the Subjects in the Clinical Trial. In addition, in the event of termination of the Agreement for reasons other than Subject safety, the SPONSOR agrees that, subject to any necessary regulatory approvals being granted, the INVESTIGATOR and the INSTITUTION shall be permitted to continue to treat Subjects with the Study Drug(s) through to completion of the schedule set out in the Protocol at the sole discretion of the Subject(s) and the INVESTIGATOR, and pursuant to accepted medical practice, and the SP...
